Cannabis ETFs get high on DEA reclassification news
The Biden admin is moving to weaken restrictions on cannabis, according to a report by the Associated Press.
Marijuana has been classified as a Schedule I drug (on par with heroin) since the Controlled Substances Act was first signed in 1970.
This change would make cannabis, which is recreationally legal in 24 states, a Schedule III drug (on par with anabolic steroids). The shift, which isn't finalized, would likely give a significant boost to the $35B legal cannabis industry through changes to its tax status.
Cannabis stocks and ETFs soared on the news.